Previous study has illustrated that Clusterin exhibited protective effects in NAFLD and western diet-induced obesity through activating AMPK and Nrf2 (Park et al. 2020). The gene discussed is CLU; the disease is metabolic dysfunction-associated steatotic liver disease.